Current status of rotational atherectomy.
Despite the increasing use of percutaneous transluminal coronary angioplasty and intracoronary stent placement for the treatment of obstructive coronary artery disease, a large subset of coronary lesions cannot be adequately treated with balloon angioplasty and/or intracoronary stenting alone. Such lesions are often heavily calcified or fibrotic and undilatable with the present balloon technology and attempts to treat them with balloon angioplasty or intracoronary stent placement often lead to vessel dissection or incomplete stent deployment with resultant adverse outcomes. Rotational atherectomy remains a useful niche device for the percutaneous treatment of such complex lesions, usually as an adjunct to subsequent balloon angioplasty and/or intracoronary stent placement. In contrast to balloon angioplasty or stent placement that widen the coronary lumen by displacing atherosclerotic plaque, rotational atherectomy removes plaque by ablating the atherosclerotic material, which is dispersed into the distal coronary circulation. Other lesion subtypes amenable to treatment with this modality include ostial and branch-ostial lesions, chronic total occlusions, and in-stent restenosis. This review discusses the technique and principles of rotational atherectomy, the various treatment strategies for its use (including adjunctive pharmacotherapy), the lesion-specific applications for this device, and the complications unique to this modality. Recommendations are also made for its use in the current interventional era.
Cavusoglu
Erdal
E
Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA.
Kini
Annapoorna S
AS
Marmur
Jonathan D
JD
Sharma
Samin K
SK
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation; D017225:Atherectomy, Coronary / Q000009:adverse effects / Q000295:instrumentation; D002317:Cardiovascular Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003324:Coronary Artery Disease / Q000473:pathology / Q000628:therapy*; D004867:Equipment Design; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D015607:Stents; D016896:Treatment Outcome
D002317:Cardiovascular Agents